Kimberly J Popovits

Director · 5 filings · Latest: Jun 17, 2026

10x Genomics, Inc.

EXACT SCIENCES CORP

Kardigan, Inc.

Kiniksa Pharmaceuticals International, plc

RHYTHM PHARMACEUTICALS, INC.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
KNSA	Kimberly J Popovits	Director	May 29, 2026	Option Exercise	—	2,799	—	15,345	Jun 2 8:51 PM
KNSA	KIMBERLY J. POPOVITS	—	Jul 30, 2025	Proposed Sale	$29.90	64,508	$1.9M	—	Jul 30 8:06 PM